Blues chief executive Scott Booth has sought to clarify the club's position ahead of Saturday's trip to Bamber Bridge and an important meeting with North Yorkshire Council.

Read more on Royals Step Out Today - One Stripe To Be King! on Sporting Post, bringing you the latest in Horse Racing News, Previews and Reviews.

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.

Clair De Lune is an improving filly who could open Murphy's account with a win in the first race, while in the Grade 2 ...

Read more on Five For Fourie As Hollywoodbets Punters' Challenge Players Strike Gold on Sporting Post, bringing you the ...

The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

NMRA stock falls after its experimental depression treatment failed to meet the primary and secondary endpoints in the first of three late-stage studies.

Neumora Therapeutics' lead candidate, navacaprant, failed to meet primary and secondary endpoints in its Phase 3 KOASTAL-1 ...

Watertown, Massachusetts Friday, January 3, 2025, 18:00 Hrs [IST] ...

Neumora Therapeutics (NMRA) announced results from the Phase 3 KOASTAL-1 Study of navacaprant for the treatment of major depressive disorder. The KOASTAL-1 Study is the first of three replicate Phase ...

Town drew 0-0 away at Briton Ferry Llansawel on New Year’s Eve in the last game of the year, in front of a bumper festive crowd of 1,384. Playing on a heavy and unfamiliar grass pitch, Barry had the ...

Massachusetts, USA-based based brain disease biotech Neumora Therapeutics shares tumbled 81.4% to 1.97 after it revealed that ...